The Global Hypertriglyceridemia Therapeutics Market is projected to exhibit a CAGR of 4% during the forecast period 2022-2028. Hypertriglyceridemia is an elevated level of triglycerides, a type of lipid, in the bloodstream. It is a condition that increases the risk of coronary artery disease in humans. Triglycerides found in the bloodstream are a combination of triglycerides […]